ABB Ltd (ABBN)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 22 Oct 2026
Key indicators
| Last close | CHF 68.92 |
|---|---|
| 52-week range | 53.78 – 89.14 |
| Return, 1 month / 3 months | −17.1% / −14.6% |
| Return, 1 year / 3 years | +21.3% / +146.4% |
| Trend | Below its 200-day average |
| RSI (14) | 26 |
| Volatility (1 year) | 29.3% |
| Worst drawdown (1 year) | -22.2% |
| Average daily value traded | 170.84M CHF |
| Dividend yield | 1.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ABB Ltd is an industrial technology company based in Zurich, Switzerland. It supplies electrification products such as switchgear, transformers and drives, and it builds industrial automation systems and robots. Its customers include utilities, manufacturers, transport operators and other industrial businesses that use its equipment and control systems to run their operations. The company also offers related services that support the installation and upkeep of the equipment it provides.
The shares are listed on the SIX Swiss Exchange in Switzerland under the code ABBN, and the price on this page is in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ABB Ltd (ABBN) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 68.92 on 22 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 117 of 225 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 21.3% and over the last three months it fell 14.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 38 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -9.0% | ||
| From 52-week high | -22.2% | ||
| Momentum | 42 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.6% | ||
| 6-month return | -10.2% | ||
| 12-month return, skipping the last month | 46.3% | ||
| Stability (higher is calmer) | 55 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.2% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 170.84M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | 37 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.4% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −9.6% |
|---|---|
| 1 month | −17.1% |
| 3 months | −14.6% |
| 6 months | −10.2% |
| 1 year | +21.3% |
| 3 years | +146.4% |
| 5 years | +177.0% |
Signals
| 50-day / 200-day average | 78.94 / 75.72 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.25 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Mar 2026 | CHF 0.9400 |
| 31 Mar 2025 | CHF 0.9000 |
| 25 Mar 2024 | CHF 0.8700 |
| 27 Mar 2023 | CHF 0.8400 |
| 3 Oct 2022 | CHF 1.2375 |
| 28 Mar 2022 | CHF 0.8200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.